navelbine 30 mg soft-gelatin capsule
pierre fabre médicament; importer: oep philippines, inc.; distributor: zuellig pharma corporation - vinorelbine (as tartrate) - soft-gelatin capsule - 30 mg
navelbine 20 mg soft-gelatin capsule
pierre fabre médicament; importer: oep philippines, inc.; distributor: zuellig pharma corporation - vinorelbine (as tartrate) - soft-gelatin capsule - 20 mg
hemangiol
pierre fabre medicament - propranolol hydrochloride - hemangioma - beta blocking agents - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.,
tardyferon
pierre fabre medicament production - iron sulfate - tablets coated - 80mg
gyno-tardyferon 80mg+0,35mg tablets prolonged-release
pierre fabre medicament production - iron sulfate, folic acid - tablets prolonged-release - 80mg+0,35mg
osteogenon tablets film-coated
pierre fabre medicament production - ossein-hydroxyapatite compound - tablets film-coated - 830mg
structum capsules
pierre fabre medicament production - chondroitin sulfate (chondroitin sulfate sodium) - capsules - 500mg
permixon 160mg capsules capsules
pierre fabre medicament production - extract lipidosterolic serenoa repens - capsules - 160mg
astrexine 5 mg/g cut. pwdr. dredg. cont.
pierre fabre médicament - chlorhexidine dihydrochloride 5 mg/g - cutaneous powder - 5 mg/g - chlorhexidine dihydrochloride 5 mg/g - chlorhexidine
balsoclase dextromethorphan 15 mg/5 ml or. sol.
pierre fabre médicament - dextromethorphan hydrobromide 0,3 g/100 ml - oral solution - 15 mg/5 ml - dextromethorphan hydrobromide 3 mg/ml - dextromethorphan